Treatment of depression with ketamine does not change plasma levels of brain-derived neurotrophic factor or vascular endothelial growth factor
Gustavo C. Medeiros, Dede Greenstein, Bashkim Kadriu, Peixiong Yuan, Lawrence T. Park, Todd D. Gould, Carlos A. Zarate
Topics & Concepts
Depression (economics)Brain-derived neurotrophic factorNeurotrophic factorsVascular endothelial growth factorKetamineMedicineNerve growth factorInternal medicinePsychologyEndocrinologyPsychiatryVEGF receptorsReceptorEconomicsMacroeconomicsTreatment of Major DepressionAnesthesia and Neurotoxicity ResearchTryptophan and brain disorders